Boothbay Fund Management’s BRAINSTORM CELL THERAPUTC BCLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-1,273
| Closed | -$39.3K | – | 1522 |
|
|
2023
Q2 | $39.3K | Hold |
1,273
| – | – | ﹤0.01% | 1464 |
|
|
2023
Q1 | $63K | Hold |
1,273
| – | – | ﹤0.01% | 1751 |
|
|
2022
Q4 | $31.3K | Hold |
1,273
| – | – | ﹤0.01% | 1657 |
|
|
2022
Q3 | $84K | Sell |
1,273
-585
| -31% | -$38.6K | ﹤0.01% | 1785 |
|
|
2022
Q2 | $77K | Sell |
1,858
-88
| -5% | -$3.65K | ﹤0.01% | 1758 |
|
|
2022
Q1 | $98K | Hold |
1,946
| – | – | ﹤0.01% | 1720 |
|
|
2021
Q4 | $117K | Hold |
1,946
| – | – | ﹤0.01% | 1514 |
|
|
2021
Q3 | $96K | Sell |
1,946
-243
| -11% | -$12K | ﹤0.01% | 1560 |
|
|
2021
Q2 | $125K | Hold |
2,189
| – | – | ﹤0.01% | 1523 |
|
|
2021
Q1 | $126K | Buy |
+2,189
| New | +$126K | ﹤0.01% | 1215 |
|
|
2020
Q4 | – | Hold |
0
| – | – | – | 1072 |
|
|
2020
Q3 | – | Hold |
0
| – | – | – | 918 |
|